FDA Extends Nexplanon Use - Top-Institutions - MDSpire

FDA Extends Nexplanon Use

US study data showed zero pregnancies in years 4 and 5 of etonogestrel implant use.

  • By

  • Kathryn Wighton

  • January 20, 2026

  • 3 min

Share

Top Institutions in Obgyn

Brief introduction explaining scope and methodology.

  • #1

    University of California, San Francisco (UCSF) School of Medicine
    University of California, San Francisco (UCSF) School of Medicine

    San Francisco, CA

    Key Differentiators

    • Obstetrics and Gynecology
    • Reproductive Endocrinology
    • Family Planning

  • #2

    Johns Hopkins University School of Medicine
    Johns Hopkins University School of Medicine

    Baltimore, MD

    Key Differentiators

    • Obstetrics and Gynecology
    • Reproductive Medicine
    • Clinical Research

  • #3

    University of Washington School of Medicine
    University of Washington School of Medicine

    Seattle, WA

    Key Differentiators

    • Obstetrics and Gynecology
    • Family Planning
    • Public Health

  • #4

    Western University of Health Sciences
    Western University of Health Sciences

    Pomona, CA

    Key Differentiators

    • Obstetrics and Gynecology
    • Reproductive Health

Original Source(s)

FDA Extends Nexplanon Use

  • by Kathryn Wighton

  • January 20, 2026

Related Content

Chemsex Knowledge Gap at the Prescription Counter

Only about one-third of pharmacy professionals could cite prescription drugs associated with chemsex contexts.

Correction: Objective interpretation of intrapartum cardiotocography images using attention-guided convolutional neural networks

Top 10 States With Rising Demand for Physicians

These 10 states report physician shortages, projected physician supply gaps, or physician-to-population ratios below national benchmarks.